BROADWOOD CAPITAL INC - AGEX THERAPEUTICS INC ownership

AGEX THERAPEUTICS INC's ticker is AGE and the CUSIP is 00848H108. A total of 31 filers reported holding AGEX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BROADWOOD CAPITAL INC ownership history of AGEX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,038,066
-23.9%
2,997,1560.0%0.18%
-9.5%
Q2 2023$2,677,060
+34.7%
2,997,1560.0%0.20%
+42.9%
Q1 2023$1,987,114
+20.1%
2,997,1560.0%0.14%
+1.4%
Q4 2022$1,654,130
-1.7%
2,997,1560.0%0.14%
+7.8%
Q3 2022$1,683,000
-2.5%
2,997,1560.0%0.13%
-1.5%
Q2 2022$1,727,000
-32.5%
2,997,1560.0%0.13%
-29.7%
Q1 2022$2,560,000
-21.6%
2,997,1560.0%0.18%
-8.0%
Q4 2021$3,267,000
+16.0%
2,997,1560.0%0.20%
+39.6%
Q3 2021$2,817,000
-39.4%
2,997,1560.0%0.14%
-30.8%
Q2 2021$4,646,000
-4.3%
2,997,1560.0%0.21%
-19.4%
Q1 2021$4,855,000
+6.6%
2,997,1560.0%0.26%
-4.4%
Q4 2020$4,556,000
+87.6%
2,997,1560.0%0.27%
+41.4%
Q3 2020$2,428,000
-14.4%
2,997,1560.0%0.19%
-14.0%
Q2 2020$2,837,000
+1.8%
2,997,1560.0%0.22%
-31.9%
Q1 2020$2,787,000
-48.9%
2,997,1560.0%0.33%
-48.2%
Q4 2019$5,455,000
-7.1%
2,997,1560.0%0.63%
-22.8%
Q3 2019$5,874,000
-46.6%
2,997,1560.0%0.82%
-40.7%
Q2 2019$11,000,000
-9.4%
2,997,1560.0%1.38%
-7.5%
Q1 2019$12,138,000
+35.5%
2,997,1560.0%1.49%
+18.1%
Q4 2018$8,961,0002,997,1561.26%
Other shareholders
AGEX THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Defender Capital, LLC. 346,805$1,379,0001.31%
BROADWOOD CAPITAL INC 2,997,156$8,961,0001.26%
Price Capital Management, Inc. 70,122$210,0000.29%
Prescott General Partners LLC 185,185$554,0000.02%
Destination Wealth Management 34,703$104,0000.01%
STATE OF WISCONSIN INVESTMENT BOARD 472,239$1,412,0000.01%
AXA S.A. 121,258$363,0000.00%
Riggs Asset Managment Co. Inc. 1,160$3,0000.00%
Banco de Sabadell, S.A 2,000$6,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 24,070$72,0000.00%
View complete list of AGEX THERAPEUTICS INC shareholders